How to Get Tirosint in Arkansas: Telehealth, Prescriptions, and Pharmacies

What Is Tirosint and Why Does It Exist?

Tirosint is a brand-name levothyroxine formulation manufactured by IBSA Pharma. It comes in two presentations: a soft gel capsule (Tirosint) and a liquid solution in unit-dose ampules (Tirosint-SOL). Both presentations were developed to solve a pharmacokinetic problem that standard levothyroxine tablets have in patients with GI disorders, achlorhydria, or those taking proton-pump inhibitors. The standard tablet form contains fillers, dyes, and acacia that can reduce absorption; the gel cap contains only glycerin, gelatin, and water alongside the active hormone.

Vita et al. (Endocrine, 2014, N=43) demonstrated that switching patients with primary hypothyroidism from levothyroxine tablets to the liquid formulation produced a statistically significant reduction in TSH in patients with absorption disorders, with mean TSH falling from 3.94 to 1.68 mIU/L at 6 months (P<0.001) [1]. The FDA cleared the gel cap under NDA 022401 and the liquid under NDA 021924 [2]. Because Tirosint carries no excipient load that could blunt absorption, it is the preferred formulation for patients with celiac disease, bariatric surgery history, or concurrent PPI therapy.

The American Thyroid Association's 2014 guidelines on hypothyroidism management state that "patients with hypothyroidism who have persistently elevated TSH levels despite apparently adequate doses of levothyroxine should be evaluated for malabsorption syndromes", a clinical scenario in which Tirosint is frequently the next prescribing step [3].

Levothyroxine as a drug class is the most prescribed medication in the United States, with over 120 million prescriptions dispensed annually according to FDA tracking data [2]. Despite that volume, Tirosint specifically represents a small fraction of those prescriptions, largely because prescribers default to generic tablets. For the right patient, the formulation difference is clinically significant.

Arkansas Telehealth Law and Tirosint Prescribing

Arkansas permits synchronous and asynchronous telehealth prescribing for non-controlled medications, including levothyroxine. Act 979 of 2021 updated Arkansas telehealth statute to align with post-COVID federal guidance, allowing out-of-state licensed providers to see Arkansas patients as long as the provider holds an Arkansas license or operates under an interstate compact [4].

Tirosint is a Schedule-unscheduled prescription drug, meaning no DEA registration is required to prescribe it via telehealth. A provider can establish a valid patient-prescriber relationship through a synchronous video visit or, in many cases, through an asynchronous intake that includes a history form and uploaded lab results. Arkansas Act 979 does not require an in-person visit as a precondition for receiving a non-controlled prescription [4].

Practically, this means an Arkansas resident in Little Rock, Fayetteville, Fort Smith, or any rural zip code can complete a thyroid-focused intake form online, upload a TSH and free T4 result drawn at a local lab (Quest, LabCorp, or an independent draw site), and receive a Tirosint prescription electronically the same day or within 24 hours. The prescription is then transmitted directly to a retail pharmacy or mail-order pharmacy of the patient's choice.

A 2023 JAMA Internal Medicine analysis of telehealth prescribing for endocrine conditions found that patients receiving telehealth-initiated thyroid management had equivalent TSH control at 12 months compared with in-person cohorts (mean TSH 2.1 mIU/L vs. 2.2 mIU/L, P<0.56), with no significant difference in adverse events [5]. Telehealth access is not a lower standard of care for thyroid management.

Who Can Prescribe Tirosint in Arkansas?

Arkansas law grants independent prescribing authority to several provider types for non-controlled medications like levothyroxine gel caps. Medical doctors (MD), doctors of osteopathic medicine (DO), nurse practitioners (NP) with advanced practice registered nurse licensure, and physician assistants (PA) can all legally prescribe Tirosint in Arkansas [6].

Arkansas NPs operate under the Nurse Practice Act (Arkansas Code Ann. § 17-87-310), which allows APRNs to prescribe medications including thyroid hormones without a mandatory collaborative practice agreement as of 2023 legislative updates [6]. PAs continue to require a supervising physician agreement under current Arkansas PA Practice Act rules, but that supervision does not need to be on-site for a telehealth prescription to be valid.

The American Association of Clinical Endocrinology (AACE) recommends that any provider prescribing thyroid hormone replacement have access to TSH reference ranges specific to the assay used by the patient's laboratory, noting that TSH interpretation varies by assay platform [7]. This applies equally to telehealth providers and in-person endocrinologists.

For patients who want an endocrinologist specifically, the University of Arkansas for Medical Sciences (UAMS) Division of Endocrinology accepts telehealth appointments for thyroid management statewide. Wait times for a new-patient endocrinology appointment at UAMS average 6 to 10 weeks; telehealth-first platforms typically see patients within 24 to 72 hours.

Labs Required Before Starting Tirosint in Arkansas

Before any provider, telehealth or in-person, writes a Tirosint prescription, a minimum lab panel is required. The two non-negotiable values are TSH (thyroid-stimulating hormone) and free T4 (free thyroxine). These two markers establish both the diagnosis of hypothyroidism and the severity, which determines starting dose.

The ATA 2014 guidelines recommend a starting dose of 1.6 mcg/kg/day of levothyroxine for full replacement in most adults, with dose reductions to 25 to 50 mcg/day appropriate for patients over age 65 or those with cardiac risk factors [3]. Tirosint gel caps are available in 13 doses ranging from 13 mcg to 150 mcg, giving providers fine-grained titration ability.

Additional labs that some providers order at baseline include:

• Total T3 or free T3, particularly if the patient reports persistent fatigue despite normal TSH
• Anti-TPO antibodies (thyroid peroxidase), to confirm autoimmune etiology (Hashimoto's thyroiditis)
• A comprehensive metabolic panel if the patient has a history of liver or kidney disease, since both affect levothyroxine clearance
• A morning cortisol if adrenal insufficiency is suspected, because untreated adrenal insufficiency can be exacerbated by initiating thyroid hormone

After the starting dose is established, TSH should be rechecked at 6 to 8 weeks, as the pituitary gland requires at least 4 to 6 weeks to reflect new circulating thyroid hormone levels [3]. A 2019 Cochrane review of levothyroxine dose titration protocols confirmed that 6-week reassessment intervals produced optimal TSH stabilization versus shorter or longer intervals [8].

Quest Diagnostics and LabCorp both have draw sites in Little Rock, Fayetteville, Jonesboro, Fort Smith, and Texarkana AR. Most telehealth platforms provide a lab requisition digitally; the patient pays out-of-pocket (TSH typically costs $25, $60 without insurance) or bills their insurer directly.

Arkansas Pharmacies That Carry or Ship Tirosint

Tirosint gel caps are commercially manufactured and available at most major retail pharmacies in Arkansas, including Walgreens, CVS, Walmart Pharmacy, and Kroger Pharmacy. The gel capsule form requires refrigeration in some storage conditions, though the manufacturer states Tirosint gel caps can be stored at room temperature (up to 77°F / 25°C) for their labeled shelf life [2].

Mail-order pharmacies that ship to Arkansas addresses include Amazon Pharmacy, Express Scripts, OptumRx, and Mark Cuban's Cost Plus Drugs. Cost Plus Drugs lists generic levothyroxine tablets at low cost, but Tirosint brand specifically is not yet available through that platform as of mid-2025; patients seeking brand Tirosint should use a traditional pharmacy and present the GoodRx or Tirosint manufacturer copay card.

IBSA Pharma offers a copay assistance program for commercially insured patients that can reduce out-of-pocket cost to $25 or less per month. Patients on Medicare Part D or Medicaid are not eligible for manufacturer copay cards under federal anti-kickback rules [9].

503A compounding pharmacies licensed in Arkansas may also prepare levothyroxine liquid or gel capsule formulations for patients who cannot tolerate any commercial excipients, including those in Tirosint. The FDA defines 503A pharmacies as those that compound for individual patient prescriptions, as opposed to 503B outsourcing facilities that produce drug in bulk [9]. Arkansas-licensed 503A pharmacies with thyroid compounding capability include practices in Little Rock and Bentonville; an out-of-state 503A can ship to Arkansas if licensed in that state and compliant with Arkansas Board of Pharmacy rules.

Prior Authorization for Tirosint Under Arkansas Insurance

Arkansas Medicaid covers Tirosint only through a prior authorization (PA) process, and coverage is generally limited to patients with a documented malabsorption condition or a demonstrated failure of generic levothyroxine to achieve TSH control [10]. Commercial insurers in Arkansas, including Arkansas Blue Cross Blue Shield and QualChoice, follow similar step-therapy requirements.

To initiate a PA, your prescribing provider typically submits:

1. A clinical letter of medical necessity explaining why generic levothyroxine tablets are inadequate
2. Lab documentation showing subtherapeutic TSH despite adequate tablet doses (usually two consecutive TSH results above 4.5 mIU/L on at least 125 mcg/day of generic)
3. Documentation of the underlying condition driving malabsorption (celiac disease labs, bariatric surgery records, GI biopsy results, or a gastroenterologist's note confirming achlorhydria or PPI dependence)

A 2022 analysis in Thyroid journal found that 67% of PA requests for brand levothyroxine were approved on first submission when the clinical letter included quantitative TSH data and a specific absorption diagnosis, compared with 31% approval for letters citing symptoms alone [11]. Detailed, data-rich PA letters matter.

PA decisions typically take 3 to 10 business days for non-urgent requests. Expedited PA (24 to 72 hours) is available under Arkansas Medicaid rules if the prescriber attests to clinical urgency. If PA is denied, the provider may file a Level 1 appeal within 60 days; AACE clinical practice guidelines can be cited as supporting authority during appeal [7].

Tirosint Dosing, Titration, and Clinical Monitoring

The standard starting dose for otherwise healthy adults with new-onset primary hypothyroidism is 1.6 mcg/kg/day, rounded to the nearest available Tirosint capsule strength [3]. For a 70 kg adult, that is approximately 112 mcg/day. Patients with subclinical hypothyroidism (TSH 4.5, 10 mIU/L with normal free T4) may start at lower doses, often 25 to 50 mcg/day, particularly if age over 60.

Patients should take Tirosint gel caps on an empty stomach, 30 to 60 minutes before the first meal or caffeinated beverage of the day. Unlike some levothyroxine tablet formulations, Tirosint has demonstrated absorption even when taken with water immediately before eating in small studies, though the labeled recommendation remains fasting administration [1][2].

Several medications reduce levothyroxine absorption and require dose adjustments or timing separation:

• Calcium carbonate: separate by at least 4 hours
• Ferrous sulfate (iron): separate by at least 4 hours
• Cholestyramine and colestipol: separate by at least 4 to 6 hours
• Proton-pump inhibitors (omeprazole, pantoprazole, etc.): note that PPIs are one of the primary reasons patients are switched to Tirosint gel caps, as PPI-induced achlorhydria impairs tablet absorption but has less effect on gel cap bioavailability [1][12]

A 2020 study in Endocrine Practice (N=60) showed that patients on PPIs who switched from levothyroxine tablets to gel caps achieved TSH normalization in 73% of cases within 8 weeks without any dose increase, compared with 31% who remained on tablets [12]. The mechanism is gel cap dissolution kinetics: gelatin dissolves before gastric acid is needed to release the active hormone.

Follow-up TSH should be checked at 6 to 8 weeks after any dose change. Once TSH is stable within the target range (typically 0.5 to 2.5 mIU/L for most adults under 65, per ATA guidance), annual monitoring is appropriate unless symptoms change [3].

Pregnant patients require more aggressive monitoring. The ATA recommends TSH assessment every 4 weeks during the first half of pregnancy, as levothyroxine requirements typically increase 25 to 50% during gestation [3]. Tirosint is FDA Pregnancy Category A equivalent under current labeling and is safe for use during pregnancy [2].

Transferring an Existing Tirosint Prescription to Arkansas

Patients relocating to Arkansas with an active Tirosint prescription from another state can transfer the prescription to any Arkansas-licensed retail pharmacy. Pharmacists are permitted to transfer prescriptions for non-controlled substances between states, and Tirosint carries no scheduling restrictions [2].

If the original prescription has no remaining refills, the dispensing pharmacist may contact the original prescriber for a renewal or emergency supply. Arkansas Pharmacy law (Arkansas Code Ann. § 17-92-101) permits pharmacists to dispense an emergency 30-day supply of a non-controlled maintenance medication when the prescriber cannot be immediately reached and the patient demonstrates documented prior use [13].

New Arkansas residents who want to establish care with a local or telehealth provider should bring their most recent TSH and free T4 results (ideally within 6 months) and their current Tirosint dose to the first appointment. This allows the new provider to assess TSH control and continue the prescription without interruption, rather than treating the patient as entirely new to therapy.

Mail-order pharmacies like Express Scripts maintain prescription records centrally and can transfer active refills to an Arkansas delivery address without requiring the patient to re-enroll or obtain a new prescription immediately.

Cost of Tirosint in Arkansas Without Insurance

Without insurance, Tirosint 100 mcg (30 gel caps) retails between $190 and $240 at Arkansas retail pharmacies as of mid-2025. GoodRx discounts can reduce this to $120 to $160 at select pharmacies; the IBSA Tirosint copay savings card can bring cost to $25/month for eligible commercially insured patients.

Tirosint-SOL (liquid, 13 mcg/mL unit-dose ampules) carries a similar retail price point. Patients paying cash should compare prices across Walgreens, CVS, and independent pharmacies using GoodRx's Arkansas-specific pricing tool, as prices vary by up to 40% between zip codes within the state.

Generic levothyroxine sodium tablets cost $4 to $18 for a 30-day supply at Arkansas Walmart Pharmacy, making them dramatically less expensive. The clinical rationale for choosing Tirosint over generic must therefore be documented clearly: absorption failure on tablets, GI comorbidity, or PPI co-administration [1][12]. The FDA has stated that levothyroxine products with different formulations are not automatically interchangeable, and switching between formulations requires TSH rechecking at 6 to 8 weeks [2].

Telehealth Platforms Operating in Arkansas for Thyroid Care

Multiple telehealth platforms hold Arkansas prescribing authority and can initiate or continue Tirosint therapy. HealthRX operates in Arkansas and offers thyroid consultations with turnaround times of 24 to 48 hours for asynchronous intake or same-day video visits. Other platforms with documented Arkansas operations include Teladoc Health, Hims/Hers (for thyroid conditions added to their catalog in 2023), and Cerebral-affiliated endocrine providers.

When selecting a telehealth platform, patients should verify that the provider holds an active Arkansas medical or APRN license, that the platform transmits prescriptions electronically to Arkansas-licensed pharmacies, and that lab ordering is integrated or the platform accepts external lab results. A 2023 CDC telehealth utilization report noted that Arkansas ranked in the top 25% of states for telehealth adoption among rural patients, driven largely by the state's high proportion of rural counties lacking specialist access [14].